Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lege Artis Pharma is a specialized German pharmaceutical company dedicated to the field of dental medicine. Established in 1954 and headquartered in Dettenhausen, the company develops, produces, and distributes a wide range of dental products, including endodontic medicaments, filling materials, and disinfectants. Their product line is designed to support dentists in performing treatments 'lege artis'—according to the recognized rules of medical science. The company maintains high quality standards in manufacturing and is a recognized leader in the European dental pharmaceutical market. Their portfolio includes well-known brands such as Calxyl and Ledermix, which are essential for root canal therapy and managing dental inflammation. As a family-owned business, Lege Artis Pharma emphasizes long-term reliability and scientific rigor in its product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lege Artis.